Smoking Cessation

The inclusion of a smoking cessation tool into electronic health records increased self-reported patient quit rates by more than 5 percentage points, according to study results.

Compared with nicotine patches, e-cigarettes were more effective in helping pregnant women stop smoking, according to data published in Nature Medicine.

SAN FRANCISCO — In a new study, researchers detected the presence of synthetic cooling agents in U.S.-marketed e-cigarettes, at levels that may exceed current safety thresholds.

Cytisinicline resulted in clinically robust and significant improvements in smoking cessation over 6 and 12 weeks of treatment compared with placebo, according to topline results from the ongoing phase 3 ORCA-2 trial.

The FDA proposed prohibiting menthol cigarettes and flavored cigars. The new product standards are designed to substantially prevent disease and death from combusted product use and to prevent young people from starting to smoke.

Incidental respiratory disease-related findings, including emphysema and reticular opacities, observed on low-dose CT lung cancer screenings were common and associated with increased mortality, researchers reported.

Researchers estimated that the lifetime benefit of smoking cessation on major cardiovascular events was similar to the use of several pharmaceutical treatments. It was the top story in cardiology last week.

The estimated lifetime treatment benefit of smoking cessation was comparable to the use of several pharmaceutical treatments combined, even when the analysis was limited to major CV events, researchers reported.

Although smoking cessation is known to benefit patients with cancer, obstacles exist at the patient, clinician and institutional levels, according to a poster presentation at American Association for Cancer Research Annual Meeting.

A new study published in JAMA highlights the prevalence of unsuccessful quit attempts among adolescents who use either e-cigarettes or cigarettes over the past 13 years.